Leadership Council

    We thank our members from all time for their service.

    Tackling an urgent need such as early cancer detection is a bold intention, and it takes partnering with people who have the experience, imagination, and long-range vision to make it happen. We thank the following people for their many contributions.

    BB

    Bill Bowes

    Founding Partner, US Venture Partners

    Canary honors the contributions of the late Bill Bowes in furthering our mission, and we appreciate his leadership from 2007-2016.

    One of our greatest partners in creating the Canary Center at Stanford was William K. Bowes Jr., known as 'Bill Bowes.' Bill was a constant guide offering support in many areas including financial, business planning, and introductions to other partners. Since those early days, a state-of-art center has been opened in Stanford's Technology and Innovation Park.

    Don Listwin

    Founder, Chairman & CEO

    Don was determined to launch a radical new assault on cancer. His target? The early cancer detection field.

    With energy and passion, Don has approached the disease as a technology and market development problem waiting to be solved. He's an engineer, an entrepreneur and a changemaker. And he thinks any problem can be fixed with the right amount of leadership, intellect and time.

    DL

    Members

    CB

    Charles Beeler

    Rally Ventures

    JB

    Jenny Beeler

    Leadership Council Member

    RD

    Reid Dennis

    Founder Institutional Venture Partners

    JD

    John Drew

    General Partner Technology Crossover Ventures

    ED

    Ellen Drew

    Leadership Council Member

    GM

    Greg McAdoo

    Partner, Sequoia Capital

    NR

    Nicki Riedel

    Partner at Dear Pixels and Black and White Designs

    HV

    Hilary Valentine

    Former Chair of Board of Directors, Room to Read

    FQ

    Frank Quattrone

    CEO, Qatalyst Group and Denise Foderaro Quattrone

    In 2006, long before the accuracy of PSA testing for prostate cancer was questioned along with issues of the over-treatment through radical procedure, Frank Quattrone and Denise Foderaro heard members of our Prostate Cancer Team talk about a fledgling idea.

    The scientists had identified a major problem in prostate cancer diagnosis; that the majority of men with prostate cancer (the percentages increase greatly with age) will die 'with' prostate cancer instead of 'from' prostate cancer. The researchers believed that men were being over treated and set out to create a clinical trial called the Prostate Cancer Active Surveillance Study, or PASS, to enroll men in a program who would opt to not get treatment unless their cancer became more aggressive.

    Leadership Vision

    Tackling an urgent need such as early cancer detection is a bold intention, and it takes partnering with people who have the experience, imagination, and long-range vision to make it happen.

    Our Leadership Council members bring decades of experience in venture capital, technology innovation, and strategic philanthropy. They provide the guidance and connections necessary to advance breakthrough cancer detection research that can save millions of lives.